Interventional Evaluation of Monoammonium Glycyrrhizinate-Glycine/DL-Methionine Combination Tablets in Mild Alopecia Areata

    Yoshiaki Kubo, Toshitatsu Nogita, Ikuko Kimura, Mami Chiba, Kanako Sakakibara
    From the encyclopedia
    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Studysummary This study suggests that combining monoammonium glycyrrhizinate/glycine/DL-methionine tablets with 5% carpronium chloride may reduce alopecia areata area more effectively than carpronium chloride alone, particularly in patients with allergic factors.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study evaluated the efficacy and safety of monoammonium glycyrrhizinate/glycine/DL-methionine (MG) tablets combined with 5% carpronium chloride (CC) in treating mild alopecia areata (AA) in 31 patients. Results showed no significant differences in efficacy between the combination therapy and CC monotherapy, but both treatments significantly reduced the AA area at 8 and 12 weeks. In patients with allergic factors, the combination therapy led to significant decreases in AA areas at 8 and 12 weeks (p<0.05). No serious adverse events were reported, suggesting that MG and CC combination therapy may offer better therapeutic effects than CC alone, particularly in patients with allergic factors.
    Discuss this study in the Community →

    Research cited in this study

    8 / 8 results